| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.23 | 7e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 9e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |